Treatment-resistant depression is when depression is unmanageable with traditional treatments, like psychiatric medications. When traditional treatment doesn’t work to help individuals manage symptoms of mental health issues, it’s important that the mental health community comes together to offer alternative treatment options in order to assist these individuals. Here at Delray Brain Science, we’re proud to offer alternative treatments to help individuals living with treatment-resistant depression, including esketamine treatment. This FDA-approved treatment for depression has allowed individuals who would otherwise be living with debilitating symptoms of depression to establish lives of mental health and wellbeing. Find out more about this treatment offering at our facility located in Delray Beach, South Florida to determine if it’s right for you.
Esketamine treatment is a quick and painless treatment that helps individuals living with symptoms of depressive disorders. Here at Delray Brain Science, we use a brand of Esketamine called Spravato, which is approved by the FDA for use in treating individuals with depression. It’s administered as a nasal spray, which is a convenient and quick way to utilize the medication. This treatment is intended for use in combination with traditional treatments, including prescribed antidepressant medications.
You may have heard that ketamine is an effective treatment option for people living with treatment-resistant depression. And, there are similarities between ketamine and esketamine, as esketamine is derived from ketamine, so it provides some of the same benefits for relieving symptoms of depression. However, ketamine must be administered with the guidance of a professional in a medical setting with an IV. So, those who don’t like needles or wish to wait for IV infusions may wish to utilize esketamine as a substitute. Esketamine also needs to be administered with the guidance of a medical professional. Patients are observed for a while after administration. But, medication enters the bloodstream immediately with the nasal inhaler. So, patients can take advantage of managing symptoms of treatment-resistant depression immediately and effectively, without having to wait and get an IV infusion. Esketamine treatments are available for administration twice weekly. And, treatments usually last four weeks. However, if needed, patients can get more treatments on a biweekly or weekly basis. This depends on the individual, patient treatment history, and experience of depressive symptoms after the four weeks of treatment.
If you or a loved one may require additional help with managing symptoms of depression, there are a few things you can expect when it comes to esketamine nasal spray treatments. First and foremost, it’s important to know that both esketamine and ketamine treatments, while effective in managing symptoms of treatment-resistant depression, are most successful when paired with other treatment approaches (including psychiatric medications). So, don’t expect to come off medications before trying these supplemental therapies. Furthermore, before treatment can commence, be prepared for an overall mental health assessment to determine if you’re a good candidate for this treatment option. Finally, along with these helpful treatments and traditional psychiatric medications, individuals who get the most out of esketamine treatments also utilize outpatient mental health services. Find out more about PHP and IOP depression treatment, group therapy options, and more available to individuals living with debilitating symptoms of depression from our website today.